Loading...
Comparison of futility monitoring guidelines using completed phase III oncology trials
BACKGROUND: Futility (inefficacy) interim monitoring is an important component in the conduct of phase III clinical trials, especially in life threatening diseases. Desirable futility monitoring guidelines allow timely stopping if the new therapy is harmful or if it is unlikely to demonstrate to be...
Na minha lista:
| Udgivet i: | Clin Trials |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5300958/ https://ncbi.nlm.nih.gov/pubmed/27590208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774516666502 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|